Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Harbour BioMed
Pharma
Takeda, Sun, Ono—Fierce Pharma Asia
Takeda sharpens its oncology focus. Sun Pharma buys PD-L1 developer Checkpoint Therapeutics. Ono obtained an ASO from Ionis. Plus more.
Angus Liu
Mar 14, 2025 8:45am
Eisai, ex-NMPA official, Pfizer-Summit—Fierce Pharma Asia
Feb 28, 2025 8:45am
Merck's GLP-1 play; Astellas' AAV deal—Fierce Pharma Asia
Dec 20, 2024 8:51am
TROP2 ADCs, Merck-Daiichi, Eisai—Fierce Pharma Asia
Aug 9, 2024 8:25am
AstraZeneca, Hengrui, Takeda—Fierce Pharma Asia
May 24, 2024 8:31am
Legend, Takeda, Pfizer and more—Fierce Pharma Asia
Apr 8, 2022 10:30am
